Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Revital Sharivkin"'
Functional proteomics screen enables enrichment of distinct cell types from human pancreatic islets.
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0115100 (2015)
The current world-wide epidemic of diabetes has prompted attempts to generate new sources of insulin-producing cells for cell replacement therapy. An inherent challenge in many of these strategies is the lack of cell-surface markers permitting isolat
Externí odkaz:
https://doaj.org/article/0c6aa824f73444eb96f95616f2b30e11
Publikováno v:
Communications in Computer and Information Science ISBN: 9783319609638
MIUA
MIUA
An increasingly common component of molecular diagnostics is the analysis of protein localization at the single-cell level using fluorescent microscopy. Manually extracting quantitative data from a large population of cells is unreasonably time-consu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10a60684f19567ac3c9029e8f4c27710
https://doi.org/10.1007/978-3-319-60964-5_66
https://doi.org/10.1007/978-3-319-60964-5_66
Publikováno v:
Molecular & Cellular Proteomics. 11:586-595
Heterogeneity, shortage of material, and lack of progenitor-specific cell surface markers are major obstacles to elucidating the mechanisms underlying developmental processes. Here we report a proteomics platform that alleviates these difficulties an
Autor:
Allan Andresson Lima Pereira, Vijaykumar Holla, Jonathan M. Loree, Kenna Rael Shaw, Oded Edelheit, Gabi Tarcic, Ben Miron, Van K. Morris, Michael Lam, Kanwal Pratap Singh Raghav, Mark J. Routbort, Nitza Burck, Michael J. Overman, Revital Sharivkin, Scott Kopetz, Michael Vidne, Funda Meric-Bernstam
Publikováno v:
Journal of Clinical Oncology. 35:3589-3589
3589 Background: Mutations (mts) in RAS predict lack of response to anti-EGFR therapy in colorectal cancer. Outside the “typical RAS” mts ( KRAS/NRAS Codons 12, 13, 59, 61, 117, 146) cited in guidelines and anti-EGFR labeling, clinical impact of
Autor:
Gabi Tarcic, B. Miron, Zohar Barbash, Michael Vidne, Oded Edelheit, Revital Sharivkin, Nir Peled
Publikováno v:
Annals of Oncology. 27:vi404
Autor:
Tatyana Rachutin Zalogin, Gabriela Ridner, Reut Bartoov-Shifman, Michael D. Walker, Keren Bahar, Tali Avnit-Sagi, Sara Weiss, Lia Kantorovich, Revital Sharivkin
Publikováno v:
Biochemical Society transactions. 36(Pt 3)
GPR40 {FFAR1 [non-esterified ('free') fatty acid receptor 1]} is a G-protein-coupled receptor expressed preferentially in pancreatic beta-cells. GPR40 functions as a receptor for medium and long-chain fatty acids, and has been implicated in mediating
Publikováno v:
Journal of Clinical Oncology. 33:e22125-e22125
e22125 Background: Two major limitation for performing precision medicine based on next generation sequencing is the lack of ability to differentiate between passenger mutations and those with onco...
Autor:
Gabriela Ridner, Reut Bartoov-shifman, Tatyana Zalogin, Tali Avnit-sagi, Keren Bahar, Revital Sharivkin, Lia Kantorovich, Sara Weiss, Michael D. Walker
Publikováno v:
Biochemical Society Transactions; 2008, Vol. 36 Issue 3, p360-362, 3p